Bleichroeder’s ImmuCell ICCC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$490K Hold
50,000
– – 0.05% 83
2026
Q2
$502K Sell
50,000
-51,594
-51% -$456K 0.09% 52
2026
Q1
$643K Hold
101,594
– – 0.11% 47
2025
Q4
$625K Hold
101,594
– – 0.11% 40
2025
Q3
$635K Hold
101,594
– – 0.12% 42
2025
Q2
$707K Hold
101,594
– – 0.17% 36
2025
Q1
$487K Hold
101,594
– – 0.13% 42
2024
Q4
$523K Hold
101,594
– – 0.13% 37
2024
Q3
$369K Hold
101,594
– – 0.1% 44
2024
Q2
$493K Hold
101,594
– – 0.15% 39
2024
Q1
$538K Hold
101,594
– – 0.13% 40
2023
Q4
$517K Hold
101,594
– – 0.11% 34
2023
Q3
$543K Hold
101,594
– – 0.13% 31
2023
Q2
$508K Hold
101,594
– – 0.1% 42
2023
Q1
$524K Hold
101,594
– – 0.11% 35
2022
Q4
$620K Hold
101,594
– – 0.13% 36
2022
Q3
$760K Hold
101,594
– – 0.16% 38
2022
Q2
$883K Buy
101,594
+30,521
+43% +$265K 0.18% 40
2022
Q1
$686K Buy
71,073
+8,824
+14% +$76.1K 0.12% 55
2021
Q4
$498K Buy
62,249
+1,642
+3% +$14.7K 0.08% 67
2021
Q3
$567K Hold
60,607
– – 0.09% 62
2021
Q2
$576K Buy
+60,607
New +$591K 0.09% 59

Other funds holding ICCC

Bleichroeder's ICCC Position: Q3 2026 in Review

Bleichroeder held its ImmuCell (ICCC) position steady in Q3 2026 at 50,000 shares worth $490K. The position accounts for 0.05% of the portfolio, ranked #83.

Bleichroeder first reported a position in ICCC in Q2 2021 and has held it in 22 quarters since. The position peaked at $883K in Q2 2022. 24 funds tracked by Wall St. Rank hold ICCC as of Q3 2026.

  • Bleichroeder held 50,000 shares of ImmuCell worth $490K as of Q3 2026.
  • Bleichroeder left its ImmuCell share count unchanged in Q3 2026.
  • ImmuCell made up 0.05% of Bleichroeder's portfolio in Q3 2026, its #83 holding.
  • Bleichroeder first reported a position in ImmuCell in Q2 2021 and has held it in 22 quarters since.
  • Bleichroeder's ImmuCell position peaked at $883K in Q2 2022.
  • 24 funds tracked by Wall St. Rank held ImmuCell as of Q3 2026.

Based on Bleichroeder's 13F filing for Q3 2026, filed 13 Nov 2026.